Navigation Links
Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
Date:8/4/2011

candidates for future development; unexpected new data, safety and/or technical issues; our clinical trials may not start when planned, be completed in a timely manner and/or confirm previous results; our clinical studies may not be predictive or achieve intended results; our product candidates, including any product candidates we decide to develop with Takeda for the treatment of obesity, may not receive regulatory approval; any financial guidance we provide may differ from our actual future financial results; and inherent scientific, regulatory and other risks associated in the drug development and commercialization process. These and additional risks and uncertainties are described more fully in Amylin's most recently filed SEC documents, including its Annual Report on Form 10-K. Amylin undertakes no duty to update these forward-looking statements.

Forward-Looking Statements Related to Takeda

This press release contains forward-looking statements about Takeda. Forward-looking statements include statements regarding Takeda's plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "assume," "continue," "seek," "pro forma," "potential," "target," "forecast," "guidance," "outlook" or "intend" or other similar words or expressions of the negative thereof. Forward-looking statements are based on estimates and assumptions made by management that are believed to be reasonable, though they are inherently uncertain and difficult to predict. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-loo
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Second Quarter Results
2. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
3. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
4. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
5. Lilly Comments on Court Ruling in Amylin Litigation
6. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
7. Lilly Provides Its Perspective in Response to Amylin Lawsuit
8. Lilly Provides Statement in Response to Amylin Lawsuit
9. Amylin Pharmaceuticals Files Suit Against Eli Lilly
10. JDRF and Amylin Partner to Investigate Co-Formulating Two Hormones for Treatment of Type 1 Diabetes
11. Amylin Pharmaceuticals to Present at the Bank of America 2011 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... UBM Medica US announces that  ... help oncologists and other clinicians gain a better understanding ... targeted therapies and immunotherapies, discusses some of the latest ... Every September, Blood Cancer Awareness Month ... blood cancers—helping to increase survival rates and improve the ...
(Date:9/19/2014)... WALTHAM, Mass. , Sept. 19, 2014  Alere ... in rapid diagnostics, issued the following statement today in ... Combating Antibiotic-Resistant Bacteria. "As the global leader ... President for establishing a national strategy to address the ... continuing to work with the Administration on initiatives to ...
(Date:9/19/2014)... Fla. , Sept. 19, 2014  The body ... with the publication of two papers this past week.  ... – Head and Neck Surgery , finds that ... and subjective measures of sleep disordered breathing, leading the ... reduction in obstructive sleep apnea severity and improvement of ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4
... Scripts (Nasdaq: ESRX ), one of the largest ... intention to release its third quarter earnings on Tuesday, October ... quarterly conference call to discuss third quarter results on Wednesday, ... Central Time). This call is being webcast and ...
... ERT ) announced today that it will release ... 27, after the market closes.  After the release, the Company ... day. For the conference call, interested participants ... 1-412-858-4600 when calling internationally. There will be a playback available ...
Cached Medicine Technology:ERT Reports Third Quarter 2011 Operating Results on October 27, 2011 2
(Date:9/21/2014)... SUNDAY, Sept. 21, 2014 (HealthDay News) -- Young women ... and know which foods they should eat. But they ... nutritional choices, according to a new study. ... the University of Illinois,s Peer Education Exercising and Eating ... what would they choose to eat if they were ...
(Date:9/21/2014)... Originally approved by the Food and ... propionate) is a synthetic ICS therapy with potent ... treatment of asthma prophylactically in children and adults. ... and HFA, which received the FDA approval in ... propionate, can bind to glucocorticoid receptors with high ...
(Date:9/21/2014)... 2014 High in the rugged Gore ... and able-bodied athletes rafted the Colorado River, rode mountain ... in pursuit of outdoor adventure. At the September 12-14 ... T.E.A.M. Sports, disabilities proved to be no more than ... three stage event. , Each participating team of five ...
(Date:9/21/2014)... September 21, 2014 “Cluster headaches are ... intense and difficult to resolve,” said Steve Young of ... think of a pain that is more intense.” , ... from cluster headaches, or migraines, that medical research is ... serotonin system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is ...
(Date:9/21/2014)... Owings Mills, Md. (PRWEB) September 21, 2014 ... K-12 school with a coed preschool in Owings Mills, Md., ... toward wellness with Garmin Vivofit bands. GFS is the first ... like steps taken, calories burned and even sleep patterns— as ... , a Baltimore area running and walking specialty chain. The ...
Breaking Medicine News(10 mins):Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Garrison Forest School Leader in Independent School Wellness Programs 2
... the risk, experts say , SUNDAY, Aug. 26 (HealthDay News) ... in many parts of the United States, can bring misery ... (hay fever). , Symptoms such as sneezing, runny noses, swollen, ... person,s ability to function normally at work or school, says ...
... multiple auras had seizures arising from one part of brain ... who experience multiple types of auras may be good candidates ... area of the brain, a U.S. study suggests. , The ... , ,included 31 epilepsy patients who experienced multiple types of ...
... teens, the beginning of a new school year is just ... the books again after a three-month-long summer break, but many ... research is emerging that sheds light on a serious problem ... are considered obese is rising dramatically. According to the ...
... , FRIDAY, Aug. 24 (HealthDay News) -- Fish oil ... patients, a U.S. study finds. , Omega-3 fatty acids ... affect blood proteins called matrix metalloproteinase-9 (MMP-9) produced by ... study was conducted by researchers at the Oregon Health ...
... to certain sounds to attract, coax infants, study finds ... with their infants, female rhesus monkeys use special vocalizations ... to get an infant,s attention, University of Chicago researchers ... form of speech, which may be biological in origin," ...
... DALLAS Aug. 23, 2007 The worlds fattest ... thanks to a glut of a key hormone, a ... are diabetic, a UT Southwestern Medical Center researcher has ... and diabetes. But in a multicenter study appearing online ...
Cached Medicine News:Health News:Ragweed Season Doesn't Mean Suffering 2Health News:Some Epilepsy Patients Are Good Candidates for Surgery 2Health News:AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic 2Health News:AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic 3Health News:AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic 4Health News:Monkey Moms Use Baby Talk, Too 2Health News:Despite overeating, morbidly obese mice gain protection against diabetes 2
... The pause of a heartbeat. The ... of rhythmic breathing. These vital signs are ... check. DeRoyals line of Temperature Monitoring products ... the information needed to provide the most ...
... pause of a heartbeat. The bodys warmth ... breathing. These vital signs are yours to ... line of Temperature Monitoring products helps you ... needed to provide the most comfortable and ...
... is a portable, compact, lightweight system with ... emitting the same intensity (50 mW/cm) of ... smaller treatment area (30 cm). Excilite- possesses ... satisfy the most demanding professional users. The ...
... Smart 1064 is a laser system with ... versions with maximum continuous intensities of either 60 ... valid ally in all-mini-invasive surgical techniques. This laser ... it is the most requested from hospitals and ...
Medicine Products: